InvestorsHub Logo
Post# of 252996
Next 10
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: None

Wednesday, 12/27/2017 10:28:03 AM

Wednesday, December 27, 2017 10:28:03 AM

Post# of 252996
Calling cancer’s bluff with neoantigen vaccines
https://www.nature.com/articles/d41586-017-08706-3

—State-of-the art tumour-genome sequencing and analysis is enabling researchers to provide uniquely personalized immunotherapy.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.